| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 121 | COMPOSITION WITH SYNBIOTICS | US14175585 | 2014-02-07 | US20140308391A1 | 2014-10-16 | Jan KNOL; Bernd Stahl |
| Nutritional compositions with health benefits comprising bacterial strains and galactooligosaccharides are disclosed. | ||||||
| 122 | NOVEL COMPOSITIONS | US14129851 | 2012-06-30 | US20140255366A1 | 2014-09-11 | Birgitte Yde |
| The invention relates to a dry compositions for lactic acid bacteria and in particular to a dry composition comprising from 109 to 1013 cfu/g of the composition of lactic acid bacteria cells, wherein the composition is characterized by that it also comprises following amounts of protective agents (all amounts of protective agents below are given relative to 1 g of lactic acid bacteria cells in the composition): from 6 to 9 g of trehalose, from 0.1 to 1 g of inulin and from 0.5 to 3 g of hydrolyzed casein, and by that it does not comprise a salt of alginic acid. The composition has an improved storage stability of the cell of interest. Comparison experiments have been made between compositions with and without alginate and it has been found that there is substantially no difference between compositions with or without alginate with regard to stability. Further, the invention relates to a method for preparing a dry lactic acid bacteria composition. | ||||||
| 123 | Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof | US11922136 | 2006-06-14 | US08101170B2 | 2012-01-24 | Regina Plail; Gerd Schatzmayr; Eva Maria Binder; Michaela Mohnl; Alfred Klimitsch; Sabine Nitsch; Viviana Klose |
| The invention relates to a probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive, comprising a mixture of microorganisms, selected from the group Enterococcus faecium, DSM 16211, Lactobacillus reuteri, DSM 16350, Lactobacillus salivarius ssp. salivarius, DSM 16351, Pediococcus acidilactici, DSM 16210, Bifidobacterium animalis and DSM 16284. The invention further relates to a use of the human or animal foodstuff and/or drinking water additive, in particular for prevention of the harmful effect of a number of undesirable germs in the digestive system of animals and/or domestic birds. | ||||||
| 124 | PROBIOTIC COMPOSITION | US12679171 | 2008-09-05 | US20100310713A1 | 2010-12-09 | Christer Viebke; Callaghan Flynn |
| A probiotic composition comprising a probiotic culture having a probiotic count of between 106 and 1010 cfu/ml or cfu/g and a carrier medium is disclosed. The invention also relates to a process for preparing the probiotic composition and to probiotic beverage and food products comprising the probiotic composition. | ||||||
| 125 | METHOD FOR DECREASING ABDOMINAL GIRTH BY ADMINISTERING A BIFIDOBACTERIUM BACTERIA | US12809174 | 2008-12-19 | US20100303763A1 | 2010-12-02 | Nathalie Goupil-Feuillerat; Denis Guyonnet; Stefan Jakob |
| A method for decreasing abdominal girth in a subject by administering a probiotic, preferably a bacteria of the Bifidobacterium genus, the method being on one aspect of the invention a non therapeutic method, and according to another aspect of the invention being a method for treating IBS. | ||||||
| 126 | TETRACYCLINE-SENSITIVE BIFIDOBACTERIA STRAINS | US12447572 | 2007-11-02 | US20100129322A1 | 2010-05-27 | Per Stroeman |
| Many probiotic Bifidobacteriacea contains an active tetW that renders the cells resistant to tetracycline. This presents a theoretical risk of a horizontal transfer of functional antibiotic genes. The present invention relates to novel tetracycline-sensitive strains of the well-known probiotic Bifidobacterium animalis subsp. lactis strain BB-12® and the use of such novel strains for the preparation of a food or feed product or a dosage form comprising viable organisms. | ||||||
| 127 | METHOD FOR TREATING AND/OR PREVENTING INFECTIONS IN INFANTS DELIVERED VIA CAESAREAN SECTION | US12091050 | 2006-10-06 | US20090221486A1 | 2009-09-03 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising uronic acid oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 128 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION | US12091011 | 2006-10-06 | US20090220639A1 | 2009-09-03 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 129 | Method for Stimulating the Intestinal Flora | US12083612 | 2006-10-20 | US20090162323A1 | 2009-06-25 | Günther Boehm; Bernd Stahl; Jan Knol |
| The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c) at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. | ||||||
| 130 | 乳酸菌および/またはビフィズス菌の生残性向上剤 | JP2016241626 | 2016-12-13 | JP2017093441A | 2017-06-01 | 越 智 大 輔; 木 村 勝 紀 |
| 【課題】酸性(pHが低い)環境にあるプロバイオティクスの乳酸菌及びビフィズス菌の生残性を向上させることができる、乳酸菌及び/又はビフィズス菌の生残性向上剤及びそれを用いた食品組成物並びにその製造方法の提供。 【解決手段】チロシン、トリプトファン、ヒスチジン、アラニン、及びこれらの混合物から選択されるアミノ酸を有効成分とする、pH2.0〜6.5の範囲の低pH環境下での乳酸菌及び/又はビフィズス菌の生残性向上剤と乳酸菌及び/又はビフィズス菌とを含んでなる、食品組成物であって、保存期間1〜4週間における乳酸菌及び/又はビフィズス菌の生残性が向上した組成物。好ましくは、食品組成物が、ヨーグルト又は発酵乳である、組成物。更に、Zn、葉酸、MgCO3、及びこれらの混合物から選択される無機塩類を含んでなる、組成物。 【選択図】なし |
||||||
| 131 | 乳酸菌および/またはビフィズス菌の生残性向上剤 | JP2012529607 | 2011-08-18 | JP6088821B2 | 2017-03-01 | 越 智 大 輔; 木 村 勝 紀 |
| 132 | ビフィドバクテリウム・アニマリスｓｓｐ．アニマリスの株 | JP2015547229 | 2013-12-10 | JP2016502842A | 2016-02-01 | ルグラン−ラスポー，ソフィー; グロンポーネ，ジャンフランコ; カプロンニエ，サンドリーヌ; スモクヴィナ，タマラ; ドジヴリ，マリ−クリスティーヌ; レシック，ビリアナ; ヌーンリスト，ミシェル |
| 本発明は、とりわけ腸管神経系の機能を改善することができるビフィドバクテリウム・アニマリスssp.アニマリスの新規株、及び該新規株を含んでなる組成物に関する。【選択図】なし | ||||||
| 133 | Fermented food products containing probiotic strains, and their preparation process | JP2014000663 | 2014-01-06 | JP2014087362A | 2014-05-15 | LUC TERRANIO; FRANCOIS DEBRUE; PHILIPP TESSIER; STEPHANE HERVE; JEAN-LUC BLACHON |
| PROBLEM TO BE SOLVED: To provide non-solid fermented food products containing bifidobacteria in a good physiological state and with a significant survival rate during a period of preservation of the fermented food products, in particular until the use-by date of the products.SOLUTION: The invention concerns a non-solid fermented food product containing ferments including about 5×10, in particular more than about 10bifidobacteria per gram of the food product, with a shelf lifetime of at least 30 days, in particular of at least 35 days. | ||||||
| 134 | Fermented food and a method of manufacturing the same, including the probiotic strain | JP2008520917 | 2006-07-11 | JP5491027B2 | 2014-05-14 | リュック テラーノ; フランソワ デブリュ; フィリップ テシエール; ステファン エルヴェ; ジャン−リュック ブラション |
| 135 | Method for decreasing abdominal girth by administering bifidobacterium bacteria | JP2014003185 | 2014-01-10 | JP2014065743A | 2014-04-17 | NATHALIE GOUPIL-FEUILLERAT; DENIS GUYONNET; STEFAN JAKOB |
| PROBLEM TO BE SOLVED: To provide means not only to partially or totally reduce small increases of abdominal girth of healthy subjects but also to partially or totally reduce more serious increases of abdominal girth of IBS patients.SOLUTION: It has been found that administration of at least about 1×10cfu of probiotics per day during at least 15 days can significantly reduce abdominal girth of subjects. | ||||||
| 136 | The use of plant extracts as prebiotics, compositions and food products containing the plant extracts | JP2012530298 | 2010-09-23 | JP2013505283A | 2013-02-14 | メラード，マルコス ペナルベル; マス，ヨゼ エー． ロペス; エー． ストライテンベルガー，セルジオ; オルティツ，ペドロ マエルティネス |
【課題】 プレバイオティックスとしての植物抽出物の使用及び当該植物抽出物を含有する組成物及び食品を提供する。 【解決手段】 本発明では、ヒトの健康増進に使用される栄養補充食品、機能性食品／飲料、食品添加物及び薬剤の製造目的のために、植物抽出物としてザクロ抽出物を様々な他の成分と併用する。 他の成分はプロバイオティック成分であり、これは、抽出物の生物活性成分と相乗効果を発揮できる。 【選択図】 図１ |
||||||
| 137 | Probiotic health and physical condition promoting food, feed and / or drinking water additives, as well as its use | JP2008516061 | 2006-06-14 | JP4846795B2 | 2011-12-28 | クリミツチ，アルフレツド; クローゼ，ビビアナ; シヤツツマイヤー，ゲルト; ニツチ，サビーネ; ビンダー，エバ−マリア; プライル，レジーナ; モーン，ミヒヤエラ |
| The invention relates to a probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive, comprising a mixture of microorganisms, selected from the group Enterococcus faecium, DSM 16211, Lactobacillus reuteri, DSM 16350, Lactobacillus salivarius ssp. salivarius, DSM 16351, Pediococcus acidilactici, DSM 16210, Bifidobacterium animalis and DSM 16284. The invention further relates to a use of the human or animal foodstuff and/or drinking water additive, in particular for prevention of the harmful effect of a number of undesirable germs in the digestive system of animals and/or domestic birds. | ||||||
| 138 | Synbiotics composition | JP2010534478 | 2008-11-20 | JP2011503225A | 2011-01-27 | クノール、ヤン; シュタール、ベルント |
| 細菌株およびガラクトオリゴサッカリドを含む健康に有益な栄養組成物を開示する。 | ||||||
| 139 | Prevention of a disease in infants which are birth by caesarean section | JP2008536530 | 2006-10-06 | JP2009512686A | 2009-03-26 | クノール、ヤン; シュミット、ヨアヒム; スタール、ベルント |
| 本発明は、帝王切開により出産された乳幼児に経腸的に投与するための組成物の製造のための、非消化性オリゴ糖を含む組成物の使用を提供する。
【選択図】 なし |
||||||
| 140 | Yogurt and a method of manufacturing the same | JP2002216850 | 2002-07-25 | JP3364491B2 | 2003-01-08 | 茂夫 松岡 |
QQ群二维码
意见反馈
意见反馈